A novel immunotherapy using modified mRNA to generate transient engineered CAR-T cells inside the body reduced fibrosis and restored cardiac function in a mouse model of heart failure, scientists at the University of Pennsylvania reported. (Hazmat2)

https://www.fiercebiotech.com/research/mrna-shot-car-t-therapy-body-repair-heart-disease-damage-university-pennsylvania